Medifast, Inc. announced that Mr. Kevin G. Byrnes will retire from the Board at the end of his current term and is not standing for re-election at the Annual Meeting of Stockholders on June 15, 2022. On the date of the Annual Meeting, the size of the Board will be reduced to seven members.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.85 USD | -0.77% | -16.28% | -67.49% |
06-05 | DA Davidson Downgrades Medifast to Underperform From Neutral With $17.50 Price Target | MT |
04-30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.49% | 234M | |
+12.21% | 8.07B | |
+8.44% | 7.84B | |
+2.57% | 6.07B | |
-6.31% | 3.71B | |
-12.74% | 3.49B | |
-16.29% | 1.15B | |
-25.10% | 1.14B | |
+10.93% | 957M | |
-13.39% | 832M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast, Inc. Announces Retirement of Kevin G. Byrnes from the Board